Revolution Medicines - Research and Markets

Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2025

From

$3,995

KRAS Inhibitors Market, Drug Sales, Patent, Price & Clinical Trials Insight 2030

From

$2,400

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

From

$2,500

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

From

$2,500

Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

From

$2,500

Drug Discovery Technologies Market by Drug Type, Assay Techniques, Technology Platforms, Application, End User - Global Forecast to 2030

From

$3,545

$3,939

Collaboration Deals in Pharmaceuticals 2019-2025

From

$3,995

Pancreatic Ductal Adenocarcinoma - Pipeline Insight, 2025

From

$3,000

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

From

$4,490

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

From

$3,995

Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032

From

$9,500

Lumakras Drug Clinical Insight & Sales Forecast 2026

From

$2,000

KRAS Inhibitors - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

From

$7,950

MTORC1 Protein Inhibitors - Pipeline Insight, 2025

From

$1,500

Pancreatic Cancer - Pipeline Review, H2 2020

From

$2,500

Antibiotics Market By Action Mechanism, By Drug Class, By Region, Industry Analysis and Forecast, 2020 - 2026

From

$3,600

Comprehensive Report on Revolution Medicines Inc, including SWOT, PESTLE and Business Model Canvas

From

$595